# Prostate Cancer Detection Rate of Targeted Biopsies With PCaVision

> **NCT06281769** · NA · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 467 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** 3D multi-parametric ultrasound targeted biopsy pathway using PcaVision
- **DIAGNOSTIC_TEST:** MRI targeted biopsy pathway

## Key facts

- **NCT ID:** NCT06281769
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-26
- **Primary completion:** 2025-08-15
- **Final completion:** 2025-08-15
- **Target enrollment:** 467 (ACTUAL)
- **Last updated:** 2025-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06281769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06281769, "Prostate Cancer Detection Rate of Targeted Biopsies With PCaVision". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06281769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*